Pioglitazone in nonalcoholic steatohepatitis

N Engl J Med. 2007 Mar 8;356(10):1068; author reply 1068-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Diabetes Mellitus, Type 2 / physiopathology
  • Disease Models, Animal
  • Fatty Liver / drug therapy*
  • Fatty Liver / pathology
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance / physiology*
  • Liver / drug effects*
  • Liver / pathology
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / pathology
  • Obesity / physiopathology
  • Pioglitazone
  • Thiazolidinediones / pharmacology*
  • Thiazolidinediones / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Pioglitazone